AI-Driven Drug Discovery and Virtual Cell Platforms
Zara Therapeutics executives detail how causal perturbation data, diffusion language models, and open-science strategies are restructuring biotech R&D. The analysis covers virtual cell commercialization, clinical trial de-risking, and the strategic shift from observational to predictive biological AI.